Owlstone Medical Breath Biopsy Kits
Owlstone Medical has launched its Breath Biopsy Kits. The kits are based on the firm's Breath Biopsy platform, which detects volatile organic compound markers in breath. The kits will allow academic, clinical, and pharmaceutical research to quickly discover and validate breath-based biomarkers for detection and precision medicine research, it said. Earlier this month, the company said that it raised $15 million for the commercialization of its breath-based diagnostic technology. Owlstone aims to bring tests for lung cancer, colorectal cancer, and asthma to market on its Breath Biopsy platform in coming years.